Sawai Pharmaceutical Adds Zomig® (zolmitriptan) to Growing Product Portfolio
Maple Grove, MN – October 30, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today reported that its parent company, Japan-based Sawai Pharmaceutical Co., Ltd. (Sawai) has entered into ... Read More
Maple Grove, MN – October 18, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the American Academy of Neurology 2017 Fall Conference in Las Vegas, October 20-22, 2017. Upsher-Smith representatives ... Read More
Qudexy® XR Now Indicated for the Prevention of Migraine Headache in Adults and Adolescents
Maple Grove, MN – August 21, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of its enhanced website for Qudexy® XR ... Read More
Maple Grove, MN – August 16, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it looks forward to attending the 2017 National Association of Chain Drug Stores (NACDS) Total Store Expo at The San ... Read More
Osaka, Japan – June 12, 2017 – – Sawai Pharmaceutical Co. Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today announced that through its subsidiary Sawai USA, Inc. (State of incorporation: Delaware) the United States ... Read More
Supports Sawai’s Goal of Building a Global Trusted Generics Company
Tokyo and Minnesota – May 31, 2017 – Sawai Pharmaceutical Co., Ltd., (Sawai) and Upsher- Smith Laboratories, LLC (Upsher-Smith) today announced that Sawai, a leading Japanese ... Read More
Building a Global Trusted Generics Company
[April 20, 2017, Tokyo and Minnesota] Sawai Pharmaceutical Co. Ltd. (“Sawai”), a leading Japanese generic pharmaceuticals manufacturer, and Upsher‐Smith Laboratories, Inc., (“Upsher‐Smith”), an established generics manufacturer based in Minnesota, U.S., today announced the signing of ... Read More
Molecule Most Prescribed by Neurologists for Migraine Prophylaxis Now Available in a Unique 24-hour Formulation
Maple Grove, MN – March 30, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has received U.S. Food and ... Read More
UPSHER-SMITH ANNOUNCES THE LAUNCH OF GENERIC CLOMIPRAMINE
Maple Grove, MN – March 22, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced the U.S. launch of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg, ... Read More
Maple Grove, MN – March 17, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has entered into an exclusive agreement with an emerging pharmaceutical company to market and distribute three generic products. These products ... Read More
